METHOD FOR COMPLEX TREATMENT OF INVASIVE CANCER OF CERVIX UTERI STAGES IIB-IIIB

The method for the complex treatment of the invasive cancer of cervix uteri stages IIb-IIIb comprises the combined radiotherapy in the setting of the oral use of hydroxyurea as radiomodifier. Throughout the course of the radiotherapy, hydroxyurea is taken at a dose of 40 mg/mL every third day. Lafer...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	SHEVCHENKO HALYNA MYKOLAIVNA, KHRULENKO TETIANA VALERIIVNA, BARANOVSKA LIDIIA MYKHAILIVNA, KURYLO HALYNA OMELIANIVNA, IVANKOVA VALENTYNA STEPANIVNA
Format:	Patent
Sprache:	eng
Schlagworte:	ELECTROTHERAPY HUMAN NECESSITIES HYGIENE MAGNETOTHERAPY MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES RADIATION THERAPY SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS ULTRASOUND THERAPY
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	The method for the complex treatment of the invasive cancer of cervix uteri stages IIb-IIIb comprises the combined radiotherapy in the setting of the oral use of hydroxyurea as radiomodifier. Throughout the course of the radiotherapy, hydroxyurea is taken at a dose of 40 mg/mL every third day. Laferon at a dose of 1.106 IU or its analogue Intron A at a dose of 1.5.106 IU is administered intramuscularly. Upon the completion of the course of the combined radiotherapy, six 10-day courses of the supporting therapy with Laferon at a dose of 1.106 IU or Intron A at a dose of 1.5.106 IU are performed within six months.